AI & Healthcare News ・ 🥗 Nutrition and diet

InBody grows overseas on obesity drug boom; Naver ties raise AI push as succession lingers

Chosunbiz · 11/15 21:01 UTC

A North America-led sales surge on premium hospital devices lifts InBody's earnings. Naver's 32.5 billion won stake has yet to yield clear revenue.

Read the original (Chosunbiz)

See it in the digest → ・ See this issue →